Many people take aspirin on a daily basis to protect themselves against problems with their heart, and studies recently suggest that aspirin could help stave off certain cancers. A recent study has added risk reductions for the developing of cancer of the liver and for dying from liver disease to a long list of benefits that aspirin can give, regardless of the frequency it is taken.
The recent study looked at over 300,000 women and men whose ages were 50 to 71 and had enrolled in a study by the AARP for health and diet. The participants were tracked on average from 10 to 12 years. All participants reported the use of non-aspirin (NSAIDs) and aspirin use for the length of the study. NSAIDs are pain relievers that include naproxen (Aleve), ibuprofen (Motrin, Advil) and some prescriptions such as Celebrex.
Researchers found that people who took aspirin were 41% less apt to develop cancer of the liver also known as hepatocellular carcinoma or HCC. They were also 45% less apt to die from CLD or chronic liver disease.
People who had taken NSAIDs, which were non-aspirin, were 26% less apt to die from a liver disease, but saw no significant protection from developing liver cancer.
Aspirin, particularly when it is taken exclusively or with other NSAID’s that are non-aspirin showed consistent protective effects that were related to both CLD mortality and HCC incidence, regardless of exclusivity or frequency of use, wrote researchers.
An August study found that people taking aspirin daily were more than 16% less apt to die from a form of cancer, compared to those people who did not take aspirin. The reduction overall had been driven partly by a reduced risk of 40% of dying from gastrointestinal, esophageal, stomach or colon cancers.